Is Solventum (SOLV) overvalued or fairly valued?

MarketChacha shows Solventum's valuation in context — a forward P/E of about 11.0, a price-to-book of about 2.7 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is the share price of Solventum (SOLV)?

Solventum last traded at $77.78 (-1.0% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

Solventum

SOLV · NYSE · Healthcare · United States

$77.78-1.0%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 5:39 PM

Snapshot

TickerSOLV

ExchangeNYSE

SectorHealthcare

IndustryMedical Instruments & Supplies

CountryUnited States

Employees20,584

HeadquartersEagan, United States

Market cap$13.5B

P/B2.7

Volume125.15K

Websitewww.solventum.com

Filings tracked0

About Solventum

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

Profile as reported by Yahoo Finance.

Who owns it

Insiders15.1%
Institutions76.4%
Public & other8.5%

1,147 institutional holders

As reported by Yahoo Finance.

Top holders

Independent Franchise Partners, LLP9.09%
Blackrock Inc.6.05%
Vanguard Capital Management LLC5.54%
Trian Fund Management, LP4.76%
State Street Corporation3.70%
Vanguard Portfolio Management LLC3.69%
Davis Selected Advisers3.66%
Geode Capital Management, LLC2.74%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

What's expected next

Next quarter

Rev $2.0B · EPS 1.41

Est. earnings growth -5.8%

Next fiscal year

Rev $8.5B · EPS 7.09

Est. earnings growth +8.2%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$62.3852-wk range$88.20

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Ask MarketChacha about SOLV

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.